Humatica Wins Actum’s Value Creation Award for a Second Time

ndetails

Humatica, the specialist advisor to private equity firms on organizational effectiveness, has been awarded Actum’s Value Creation Award in the People & Organizational Strategy category—for the second time.

The award highlights Humatica’s deep expertise in organizational transformation, developed over more than two decades of partnering with demanding buy-out CEOs and GPs globally.

In a year marked by strong momentum, Humatica achieved over 60% growth in 2024, expanded its global presence with new offices in Paris and New York, and made significant advancements in its AI-enabled tools. These milestones contributed to the firm being recognized as the go-to advisor for driving efficiency and effectiveness in private equity portfolio companies.

“We are honored to receive this recognition once again,” said Andros Payne, Founder of Humatica. “It reflects the trust our clients place in us and our continued commitment to delivering measurable impact through world-class organizational strategies.”

The Actum Awards celebrate outstanding contributors to value creation in private equity, based on innovation, execution, and results.

Related News

Experienced Private Equity executive Melissa Mounce joins Humatica to build the firm’s presence in the US
17 Feb, 2025 By Humatica

Experienced Private Equity executive Melissa Mounce joins Humatica to build the firm’s presence in the US

Humatica, the leading private equity specialist advisor for organizational effectiveness, is pleased to announce that Melissa Mounce has joined the firm as an Operating Partner…

Read more arrowicon
Humatica finalist for two prestigious PE Awards
03 Feb, 2025 By Humatica

Humatica finalist for two prestigious PE Awards

Humatica has been named a finalist for the Actum Awards as Value Creation Firm of the Year (People and Organisational Strategy) and for the Real Deals Private Equity Awards 2025 in…

Read more arrowicon
Humatica 2024 in Review and Outlook 2025
17 Dec, 2024 By Humatica

Humatica 2024 in Review and Outlook 2025

2024 was a milestone year for private equity, and for Humatica. The industry is under greater pressure to generate acceptable returns than ever before. With…

Read more arrowicon

Subscribe to our Monthly Newsletter and other News Updates

Receive our news and valuable perspectives on organizational effectiveness each month.